vs

Side-by-side financial comparison of Align Technology (ALGN) and SSR MINING INC. (SSRM). Click either name above to swap in a different company.

Align Technology is the larger business by last-quarter revenue ($1.0B vs $521.7M, roughly 2.0× SSR MINING INC.). SSR MINING INC. runs the higher net margin — 34.8% vs 10.8%, a 23.9% gap on every dollar of revenue. On growth, SSR MINING INC. posted the faster year-over-year revenue change (61.4% vs 6.2%). Over the past eight quarters, SSR MINING INC.'s revenue compounded faster (50.5% CAGR vs 0.6%).

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandib...

SSR Mining Inc., formerly Silver Standard Resources is a Denver-based gold, silver, copper, lead and zinc producer that owns the largest silver mine in Argentina. In addition it engages in exploration activity throughout the Americas and Turkey. In 2020, SSR Mining merged with Alacer Gold. Since the merger, the company has moved headquarters to Denver, Colorado. Rodney P. Antal is now the president and CEO of SSR mining. In February 2021, SSR Mining announced that Alison White would be the ne...

ALGN vs SSRM — Head-to-Head

Bigger by revenue
ALGN
ALGN
2.0× larger
ALGN
$1.0B
$521.7M
SSRM
Growing faster (revenue YoY)
SSRM
SSRM
+55.2% gap
SSRM
61.4%
6.2%
ALGN
Higher net margin
SSRM
SSRM
23.9% more per $
SSRM
34.8%
10.8%
ALGN
Faster 2-yr revenue CAGR
SSRM
SSRM
Annualised
SSRM
50.5%
0.6%
ALGN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ALGN
ALGN
SSRM
SSRM
Revenue
$1.0B
$521.7M
Net Profit
$112.8M
$181.5M
Gross Margin
70.8%
Operating Margin
13.6%
38.8%
Net Margin
10.8%
34.8%
Revenue YoY
6.2%
61.4%
Net Profit YoY
21.0%
3166.6%
EPS (diluted)
$1.57
$0.84

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALGN
ALGN
SSRM
SSRM
Q1 26
$1.0B
Q4 25
$1.0B
$521.7M
Q3 25
$995.7M
$385.8M
Q2 25
$1.0B
$405.5M
Q1 25
$979.3M
$316.6M
Q4 24
$995.2M
$323.2M
Q3 24
$977.9M
$257.4M
Q2 24
$1.0B
$184.8M
Net Profit
ALGN
ALGN
SSRM
SSRM
Q1 26
$112.8M
Q4 25
$135.8M
$181.5M
Q3 25
$56.8M
$65.4M
Q2 25
$124.6M
$90.1M
Q1 25
$93.2M
$58.8M
Q4 24
$103.8M
$5.6M
Q3 24
$116.0M
$10.6M
Q2 24
$96.6M
$9.7M
Gross Margin
ALGN
ALGN
SSRM
SSRM
Q1 26
70.8%
Q4 25
65.3%
Q3 25
64.2%
Q2 25
69.9%
Q1 25
69.5%
Q4 24
70.0%
Q3 24
69.7%
Q2 24
70.3%
Operating Margin
ALGN
ALGN
SSRM
SSRM
Q1 26
13.6%
Q4 25
14.8%
38.8%
Q3 25
9.7%
21.6%
Q2 25
16.1%
26.9%
Q1 25
13.4%
21.1%
Q4 24
14.5%
10.6%
Q3 24
16.6%
3.5%
Q2 24
14.3%
5.8%
Net Margin
ALGN
ALGN
SSRM
SSRM
Q1 26
10.8%
Q4 25
13.0%
34.8%
Q3 25
5.7%
17.0%
Q2 25
12.3%
22.2%
Q1 25
9.5%
18.6%
Q4 24
10.4%
1.7%
Q3 24
11.9%
4.1%
Q2 24
9.4%
5.2%
EPS (diluted)
ALGN
ALGN
SSRM
SSRM
Q1 26
$1.57
Q4 25
$1.88
$0.84
Q3 25
$0.78
$0.31
Q2 25
$1.72
$0.42
Q1 25
$1.27
$0.28
Q4 24
$1.40
$0.03
Q3 24
$1.55
$0.05
Q2 24
$1.28
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALGN
ALGN
SSRM
SSRM
Cash + ST InvestmentsLiquidity on hand
$1.1B
$575.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.1B
$3.5B
Total Assets
$6.3B
$6.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALGN
ALGN
SSRM
SSRM
Q1 26
$1.1B
Q4 25
$1.1B
$575.6M
Q3 25
$1.0B
$445.4M
Q2 25
$901.2M
$438.5M
Q1 25
$873.0M
$341.3M
Q4 24
$1.0B
$417.3M
Q3 24
$1.0B
$365.8M
Q2 24
$761.4M
$384.4M
Total Debt
ALGN
ALGN
SSRM
SSRM
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$228.6M
Q3 24
$228.3M
Q2 24
$228.0M
Stockholders' Equity
ALGN
ALGN
SSRM
SSRM
Q1 26
$4.1B
Q4 25
$4.0B
$3.5B
Q3 25
$4.0B
$3.3B
Q2 25
$3.9B
$3.3B
Q1 25
$3.8B
$3.2B
Q4 24
$3.9B
$3.1B
Q3 24
$3.9B
$3.1B
Q2 24
$3.8B
$3.1B
Total Assets
ALGN
ALGN
SSRM
SSRM
Q1 26
$6.3B
Q4 25
$6.2B
$6.1B
Q3 25
$6.2B
$5.9B
Q2 25
$6.2B
$5.8B
Q1 25
$6.1B
$5.6B
Q4 24
$6.2B
$5.2B
Q3 24
$6.4B
$5.1B
Q2 24
$6.2B
$5.2B
Debt / Equity
ALGN
ALGN
SSRM
SSRM
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.07×
Q3 24
0.07×
Q2 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALGN
ALGN
SSRM
SSRM
Operating Cash FlowLast quarter
$151.0M
$172.1M
Free Cash FlowOCF − Capex
$106.4M
FCF MarginFCF / Revenue
20.4%
Capex IntensityCapex / Revenue
12.6%
Cash ConversionOCF / Net Profit
1.34×
0.95×
TTM Free Cash FlowTrailing 4 quarters
$241.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALGN
ALGN
SSRM
SSRM
Q1 26
$151.0M
Q4 25
$223.2M
$172.1M
Q3 25
$188.7M
$57.2M
Q2 25
$128.7M
$157.8M
Q1 25
$52.7M
$84.8M
Q4 24
$286.1M
$95.0M
Q3 24
$263.7M
$-1.3M
Q2 24
$159.8M
$-78.1M
Free Cash Flow
ALGN
ALGN
SSRM
SSRM
Q1 26
Q4 25
$187.3M
$106.4M
Q3 25
$169.0M
$-2.4M
Q2 25
$107.2M
$98.4M
Q1 25
$27.4M
$39.3M
Q4 24
$263.1M
$56.4M
Q3 24
$233.9M
$-34.1M
Q2 24
$106.4M
$-116.3M
FCF Margin
ALGN
ALGN
SSRM
SSRM
Q1 26
Q4 25
17.9%
20.4%
Q3 25
17.0%
-0.6%
Q2 25
10.6%
24.3%
Q1 25
2.8%
12.4%
Q4 24
26.4%
17.5%
Q3 24
23.9%
-13.2%
Q2 24
10.3%
-62.9%
Capex Intensity
ALGN
ALGN
SSRM
SSRM
Q1 26
Q4 25
3.4%
12.6%
Q3 25
2.0%
15.4%
Q2 25
2.1%
14.7%
Q1 25
2.6%
14.4%
Q4 24
2.3%
11.9%
Q3 24
3.0%
12.7%
Q2 24
5.2%
20.7%
Cash Conversion
ALGN
ALGN
SSRM
SSRM
Q1 26
1.34×
Q4 25
1.64×
0.95×
Q3 25
3.33×
0.87×
Q2 25
1.03×
1.75×
Q1 25
0.57×
1.44×
Q4 24
2.76×
17.10×
Q3 24
2.27×
-0.13×
Q2 24
1.66×
-8.06×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALGN
ALGN

Clear Aligner$856.0M82%
CAM Services$184.1M18%

SSRM
SSRM

Gold$369.3M71%
Concentrate Sales$124.4M24%
Other$19.1M4%
Lead$9.0M2%

Related Comparisons